Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $608,580 - $801,208
-15,120 Closed
0 $0
Q1 2024

Aug 13, 2024

BUY
$47.98 - $54.4 $352,413 - $399,568
7,345 Added 94.47%
15,120 $819,000
Q4 2023

Aug 13, 2024

BUY
$48.48 - $57.85 $376,932 - $449,783
7,775 New
7,775 $398,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Correct Capital Wealth Management Portfolio

Follow Correct Capital Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Correct Capital Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Correct Capital Wealth Management with notifications on news.